Decision Support Tool for Patients With Advanced Breast Cancer (NCT07635147)
Communicating Options for Advanced Breast Cancer Support and Treatment (COAST)
🩺 Plain-English Summary (8th-Grade Level)
The goal of this pilot study is to understand and improve the shared decision-making process between people with advanced breast cancer and their providers regarding their care and treatment. As part of this study, the researchers will evaluate a decision support tool called COAST that was designed to support patients and providers in having meaningful conversations. The main questions it aims to answer are: 1. Can the COAST tool improve the quality of communication between patients and their oncology providers? 2. Is the COAST tool acceptable, appropriate, and easy to use at NYP-Weill Cornell Medicine, NYP-Brooklyn Methodist Hospital and NYP-Queens? Participants will be asked to fill out two surveys: one before they use the COAST tool and another about 2 - 4 weeks later. Some patients will also be invited for an interview.
Who can join: Review the eligibility criteria below.
Location: NewYork-Presbyterian Brooklyn Methodist Hospital — Brooklyn, New York
Age range: 18 Years
🧪 Interventions in This Study
- Decision Support Tool (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (3 Sites)
- NewYork-Presbyterian Brooklyn Methodist Hospital — Brooklyn, New York
- NewYork-Presbyterian Medical Group Queens — Flushing, New York
- NewYork-Presbyterian David H. Koch Center — New York, New York
📞 Contact the Study Coordinator
Phone: (646) 962-3694
Email: zkh4001@med.cornell.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Breast Cancer Metastatic
- A Study to Assess Overall Response Rate by Inducing an Inflammatory Phenotype in Metastatic BReast cAnCEr With the Oncolytic Reovirus PeLareorEp in CombinaTion With Anti-PD-L1 Avelumab and Paclitaxel - BRACELET-1 Study — Miami, Florida
- Olaparib in Combination With Vorinostat in Patients With Relapsed/Refractory and/or Metastatic Breast Cancer — Houston, Texas
- Clinical Trial of Avasopasem in Patients With Metastatic Hormone Receptor Positive Breast Cancer With Progression on a CDK 4/6 Inhibitor and Hormonal Therapy — San Antonio, Texas
- HER2-PET Imaging in HER2-low Breast Cancers — Sherbrooke, Quebec
- Trial of Trastuzumab Deruxtecan in Previously Treated HER2 — New Haven, Connecticut
Explore by condition: All Breast Cancer Metastatic clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.